<DOC>
	<DOCNO>NCT02218346</DOCNO>
	<brief_summary>AG-221 first-in-class drug target specifically inhibit IDH2 enzyme . Small molecule inhibition IDH enzyme represent new , targeted approach cancer treatment . Administration oral drug food may change absorption drug , therefore useful characterize effect food early drug development .</brief_summary>
	<brief_title>Food Effect Study AG-221 Healthy Male Subjects</brief_title>
	<detailed_description />
	<criteria>1 . Healthy adult male subject 18 56 year age , inclusive , Screening . 2 . Subjects able understand sign inform consent prior conduct protocolspecific screening procedure . 3 . Subjects must willing able complete study assessment procedure . 4 . Subjects , exception undergone vasectomy least 6 month prior Screening , must agree use condom spermicide contraception ( regardless female partner 's childbearing potential partner 's use contraception ) Day 1 Period 1 28 day follow last dose study drug . 5 . Subjects must body weight ≥50 kg body mass index ( BMI ) ≥18.5 ≤32 kg/m2 Screening . 6 . Subjects must general good health determine clinically significant deviation normal medical history , physical examination , vital sign , 12lead ECGs Screening Day 1 period . 7 . Subjects must nonsmoker use nicotinecontaining product least 3 month prior Screening . 8 . Subjects must willing refrain caffeine xanthenecontaining product ( coffee , tea , cola , chocolate , etc . ) 48 hour prior dose period discharge study center . 9 . Subjects must willing refrain strenuous exercise start 72 hour prior Day 1 Period 1 Followup visit . 10 . Subjects must willing refrain ingestion alcohol start 7 day ( 14 day red wine ) prior Day 1 Period 1 Followup visit . 11 . Subjects must agree donate blood plasma blood bank purpose ( blood sample study ) duration participation study ( Screening Followup ) . Subjects meet follow criterion enrol study : 1 . Subjects previously receive AG221 ( apply Period 2 ) . 2 . Subjects Screening Checkin clinical laboratory result outside laboratory normal range , include hematology , clinical chemistry , serology , urinalysis , Investigator 's judgment , felt clinically relevant . 3 . Subjects , 10 minute supine rest , systolic blood pressure ( BP ) &gt; 144 mmHg diastolic BP &gt; 90 mmHg . If BP exceed cut point related transient anxietyrelated increase , BP may repeat . 4 . Subjects QTcF interval ( Fridericia 's correction factor ) &gt; 450 msec Screening pre dose Day 1 either study period . 5 . Subjects history serious mental illness include , limited , schizophrenia , bipolar disorder , major depression . Subjects history depression may include treatment require hospitalization , subject antidepressant medication minimum 12 month , Investigator 's judgment , subject stable evidence significant depression minimum 12 month . 6 . Subjects clinically relevant history presence respiratory , gastrointestinal , renal , cardiovascular , hepatic , hematologic , lymphatic , neurologic , endocrine , psychiatric , musculoskeletal , genitourinary , immunologic , dermatologic , connective tissue diseases disorder . 7 . Subjects history primary malignancy , include history melanoma suspicious undiagnosed skin lesion , exception basal cell squamous cell carcinoma skin cervical carcinoma situ malignancy curatively treat evidence disease least 1 year prior Screening . 8 . Subjects preexist condition interferes normal gastrointestinal anatomy motility , and/or hepatic and/or renal function could interfere absorption , metabolism , and/or excretion study drug . Note cholecystectomy exclusionary . 9 . Subjects medical psychological condition , deem Investigator likely interfere subject 's ability sign inform consent , cooperate , participate study . 10 . Subjects undergone major surgery within 6 month prior Screening . 11 . Subjects test positive hepatitis B surface antigen ( HBsAg ) , hepatitis C virus ( HCV ) human immunodeficiency virus ( HIV ) infection 1 2 . 12 . Subjects donate blood , blood loss 500 mL , receive transfusion blood plasma within 3 month prior Screening . 13 . Subjects history illicit drug abuse alcoholism within 12 month prior Screening . 14 . Subjects consume 21 unit alcohol week ( 1 unit = 5 ounce wine , 12 ounce beer , 1.5 ounce hard liquor ) . 15 . Subjects positive screen drug abuse , urinary cotinine &gt; 200 ng/mL Screening Checkin ; subject positive screen alcohol Checkin . 16 . Subjects participate concurrent clinical trial another investigational product placebo , receive investigational agent within 2 month prior Day 1 Period 1 . 17 . Subjects use prescription drug within 2 week 5 halflives ( whichever longer ) dose Day 1 Period 1 . 18 . Subjects use overthecounter ( OTC ) medication ( exclude routine vitamin ) within 7 day dose Day 1 Period 1 , unless agree clinically relevant Investigator Sponsor 's Medical Monitor . Note : use acetaminophen dose great 2 g 24 hour period 48 hour prior study drug dosing allow . 19 . Subjects used St. John 's Wort within 28 day dose Day 1 Period 1 . 20 . Subjects unwilling forgo consumption red wine , Seville oranges , grapefruit grapefruit juice and/or pomelo , exotic citrus fruit , grapefruit hybrid 14 day prior dose Day 1 Period 1 Followup visit . 21 . Subjects unwilling forgo consumption fruit juice , charbroiled meat , vegetable mustard green family ( e.g. , kale , broccoli , watercress , collard green , kohlrabi , brussels sprout , mustard ) 7 day prior dose discharge clinic period . 22 . Subjects undergone strenuous activity within 72 hour prior Day 1 period . 23 . Subjects unable ( e.g. , food intolerance ) unwilling consume highfat breakfast within 30 minute . 24 . Subjects propensity sunburn skin condition make unsuitable current study . 25 . Subjects communicate reliably Investigator . 26 . Subjects unlikely cooperate requirement study ( example , difficulty swallow multiple tablet medication ) . 27 . Subjects condition , opinion Investigator , would make subject unsuitable enrollment could interfere subject 's participation , completion , study .</criteria>
	<gender>Male</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>56 Years</maximum_age>
	<verification_date>December 2015</verification_date>
	<keyword>Healthy volunteer</keyword>
</DOC>